IMPROVING HEALTHSPAN AND INCREASING LIFESPAN

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Oct 2024 filing date already counts against anyone who files later.

Record

Serial number

98825813

Mark type

Stylized text

Filed

29 Oct 2024

Published for opposition

30 Dec 2025

Attorney of record

Jared L. DuJack

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Gene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders
• Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Testing, inspection, research, or development of pharmaceutical preparations for age therapy and gene therapy; Consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics; Medical research services; Medical research services, namely, anti-aging services; Medical research services, namely, prevention and treatment of age-related disorders; Medical research laboratory services; Medical research laboratory services related to biologic age; Medical research laboratory services related to biological age scoring; Medical research laboratory services related to determining a number or percentage of senescent cells
• Class 044 — Medical, beauty and agricultural services: Medical clinic providing anti aging therapy; Medical clinic providing anti aging therapy services; Consulting services related to medical laboratory testing and diagnostic medical testing; Medical testing services, namely, biologic age scoring; Medical testing services, namely, statistical scoring to determine a biologic age score of a patient; Medical services; Medical services, namely, anti-aging services; Medical services, namely, prevention and treatment of age-related disorders; Medical advisory services; Medical advisory services, namely, anti-aging services; Medical advisory services, namely, prevention and treatment of age-related disorders; Medical testing services; Medical testing services, namely, anti-aging services; Medical testing services, namely, prevention and treatment of age-related disorders; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Medical testing services, namely, biopsy services; Medical testing services, namely, biopsy services related to biologic age; Medical testing services, namely, biopsy services related to biological age scoring; Medical testing services, namely, biopsy services related to determining a number or percentage of senescent cells; Medical testing services, namely, non-invasive testing; Medical testing services, namely, non-invasive testing related to biologic age; Medical testing services, namely, non-invasive testing related to biologic age scoring; Medical testing services, namely, non-invasive testing related to determining a number or percentage of senescent cells

Owner

• Senotherapeutix, Inc., Surfside, FL, US
• Senotherapeutix, Inc., Surfside, FL, US

Prosecution history

• 24 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 30 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 30 Dec 2025 — PUBLISHED FOR OPPOSITION
• 24 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 03 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 05 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 05 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 05 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 05 Aug 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
• 05 Aug 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
• 05 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 05 May 2025 — NON-FINAL ACTION E-MAILED
• 05 May 2025 — NON-FINAL ACTION WRITTEN
• 29 Apr 2025 — ASSIGNED TO EXAMINER
• 28 Apr 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED